Showing results (171-180 of 201) with videos related to

Sort By:
Pageof 21
The Prostate|January 1, 1988
Antiestrogens do not counteract the inhibitory effect of estradiol-17 beta on the growth of the Dunning R3327 prostatic adenocarcinomaM Landström, J E Damber, A Bergh, et al.
Scandinavian Journal of Urology and Nephrology|November 30, 2000
Evaluation of prognostic factors in prostate cancer with partial least squares analysisP Wikström, P Wikström, I F Lissbrant, et al.
International Journal of Oncology|August 12, 2000
Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survivalI F Lissbrant, P Stattin, P Wikstrom, et al.
International Journal of Radiation Oncology, Biology, Physics|December 10, 1997
Combined castration and fractionated radiotherapy in an experimental prostatic adenocarcinomaT Granfors, J E Damber, A Bergh, et al.
Acta Endocrinologica|September 1, 1981
Luteal blood flow and plasma steroids in rats with corpora lutea of different agesJ E Damber, P O Janson, C Axén, et al.
Genes, Chromosomes & Cancer|November 7, 2000
Low frequency of allelic imbalance at the prostate cancer susceptibility loci HPC1 and 1p36 in Swedish men with hereditary prostate cancerA K Ahman, B A Jonsson, J E Damber, et al.
Maturitas|December 1, 1981
Effects of various oestrogens on circulating androgens and cortisol during replacement therapy in post-menopausal womenS Helgason, K Carlström, M G Damber, et al.
International Journal of Cancer|August 7, 1996
Estrogen induces apoptosis in a rat prostatic adenocarcinoma: association with an increased expression of TGF-beta 1 and its type-I and type-II receptorsM Landström, S Eklöv, P Colosetti, et al.
European Journal of Cancer (Oxford, England : 1990)|March 31, 2000
Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancerO Bratt, J E Damber, M Emanuelsson, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1982
A comparative longitudinal study on sex hormone binding globulin capacity during estrogen replacement therapyS Helgason, J E Damber, M G Damber, et al.
Pageof 21